0RP

ethyl (2R,4S)-4-{[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H )-carboxylate

Created: 2012-05-03
Last modified:  2020-06-05

Find related ligands:

Chemical Details

Formal Charge0
Atom Count66
Chiral Atom Count2
Bond Count68
Aromatic Bond Count12
2D diagram of 0RP

Chemical Component Summary

Nameethyl (2R,4S)-4-{[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H )-carboxylate
SynonymsTorcetrapib
Systematic Name (OpenEye OEToolkits)ethyl (2R,4S)-4-[[3,5-bis(trifluoromethyl)phenyl]methyl-methoxycarbonyl-amino]-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinoline-1-carboxylate
FormulaC26 H25 F9 N2 O4
Molecular Weight600.473
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs12.01FC(F)(F)c1cc(cc(c1)C(F)(F)F)CN(C(=O)OC)C3c2c(ccc(c2)C(F)(F)F)N(C(=O)OCC)C(C3)CC
SMILESCACTVS3.370CCOC(=O)N1[CH](CC)C[CH](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)OC)c3cc(ccc13)C(F)(F)F
SMILESOpenEye OEToolkits1.7.6CCC1CC(c2cc(ccc2N1C(=O)OCC)C(F)(F)F)N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)C(=O)OC
Canonical SMILESCACTVS3.370 CCOC(=O)N1[C@H](CC)C[C@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)OC)c3cc(ccc13)C(F)(F)F
Canonical SMILESOpenEye OEToolkits1.7.6 CC[C@@H]1C[C@@H](c2cc(ccc2N1C(=O)OCC)C(F)(F)F)N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)C(=O)OC
InChIInChI1.03 InChI=1S/C26H25F9N2O4/c1-4-18-12-21(19-11-15(24(27,28)29)6-7-20(19)37(18)23(39)41-5-2)36(22(38)40-3)13-14-8-16(25(30,31)32)10-17(9-14)26(33,34)35/h6-11,18,21H,4-5,12-13H2,1-3H3/t18-,21+/m1/s1
InChIKeyInChI1.03 CMSGWTNRGKRWGS-NQIIRXRSSA-N

Drug Info: DrugBank

DrugBank IDDB06281 
NameTorcetrapib
Groups investigational
DescriptionTorcetrapib (CP-529414, Pfizer) was developed to treat hypercholesterolemia but its development was halted in 2006 when phase III studies showed excessive mortality in the treatment group receiving a combination of atorvastatin and the study drug.
SynonymsTorcetrapib
IndicationInvestigated for use/treatment in peripheral vascular disease and hyperlipidemia.
Categories
  • Anticholesteremic Agents
  • Blood Pressure
  • Cholesterol Ester Transfer Proteins
  • Heterocyclic Compounds, Fused-Ring
  • Hypolipidemic Agents
CAS number262352-17-0

Drug Targets

NameTarget SequencePharmacological ActionActions
Cholesteryl ester transfer proteinMLAATVLTLALLGNAHACSKGTSHEAGIVCRITKPALLVLNHETAKVIQT...unknownantagonist
Cytochrome P450 11B2, mitochondrialMALRAKAEVCVAAPWLSLQRARALGTRAARAPRTVLPFEAMPQHPGNRWL...unknowninducer
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL479527
PubChem 159325
ChEMBL CHEMBL479527
ChEBI CHEBI:49203